A new study from the University of Cincinnati has found a sharp increase in the use of nicotine pouches among American adults who use tobacco products, raising concerns among public health researchers about the product's unknown long-term effects.
Ashley Merianos, a professor in UC's School of Human Services and the lead investigator of the study, spoke with Local 12 news about the findings, which were published in the journal Addiction. According to the research, the share of adult tobacco users who had tried a nicotine pouch at least once — classified as "ever users" — rose from 16.4% in 2021 to 31.1% in 2024. Current use, defined as having used a pouch in the past 30 days, increased from 3% to 10.2% over the same period.
Nicotine pouches are small, smokeless products containing a powder made of nicotine, flavorings and other ingredients. Users place a pouch between their lip and gum, where saliva releases the nicotine, which is then absorbed through the lining of the mouth. Unlike traditional chewing tobacco or snus, nicotine pouches do not contain tobacco leaf, which has contributed to a perception that they are a cleaner or safer alternative.
Merianos told Local 12 that the data, drawn from national YouGov surveys, shows usage was more common in 2024 among men, adults aged 21 to 45, and people already using other tobacco products — particularly smokeless tobacco users. This pattern, she said, suggests that nicotine pouches may be used alongside other forms of tobacco rather than replacing them.
"They have been deemed less harmful than traditional cigarettes, but less harmful does not mean no harm," Merianos said in the interview. "And so we need more studies that are long-term to figure out the overall impact that they are going to have on the health of the U.S."
For university students, the findings are a reminder that the landscape of nicotine products is shifting rapidly. Nicotine pouches are often sold in sleek, discreet packaging and marketed with flavors that can appeal to younger adults. While they are not the same as vaping, they share a similar trajectory: a product initially positioned as a harm-reduction tool that later drew scrutiny as use expanded beyond the intended audience of established smokers trying to quit.
The study's results were also reported by US News & World Report, StudyFinds and HealthDay, and aired in short segments on television broadcasts across the country. Merianos's research adds to a growing body of work examining the public health implications of novel nicotine delivery systems. Because nicotine pouches are relatively new to the U.S. market — having gained significant traction only in the last few years — long-term health data is sparse. Researchers do not yet know how chronic use affects cardiovascular health, oral tissue, or the likelihood of transitioning to other tobacco products.
Merianos's warning is not that nicotine pouches are as dangerous as cigarettes, but that the absence of evidence of harm is not the same as evidence of safety. For students who may encounter these products on campus or in social settings, the key takeaway, according to the researcher, is that "less harmful" is not a free pass.